SciSparc Announces Initiation of Randomized Phase IIb Clinic

SciSparc Announces Initiation of Randomized Phase IIb Clinical Trial of its Proprietary SCI-110 for Tourette Syndrome

SciSparc Announces Initiation of Randomized Phase IIb Clinical Trial of its Proprietary SCI-110 for Tourette Syndrome

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Hannover , Niedersachsen , Germany , Connecticut , United States , Israel , Israeli , Oz Adler , Yale Child Study Center , Company Or Scisparc , Hannover Medical School , Tel Aviv Sourasky Medical Center , Yale School Of Medicine , Hannover Medical School In , Israeli Ministry Of Health , Exchange Commission , Nasdaq , Scisparc Ltd , Institute For Drugs , Clinical Trial , Tourette Syndrome , Yale School , Chief Executive Officer , Institutional Review Board , Israeli Ministry , Federal Institute , Medical Devices , Hannover Medical , Yale Global Tic Severity Scale , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,